Skip to main content
OpenTrials
Completed

NCT Number: NCT00170131

MMF Influence on HCV Viral Evolution After Liver Transplantation

Samples from a large clinical trial comparing three immunosuppression regimens, two of which contained MMF, are used to identify the HCV viral quasispecies behaviour after liver transplantation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic

Scottsdale, Arizona, 85259, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

All patients enrolled into - An Open Randomized, Prospective Multicenter Study to Compare the Efficacy and Safety Among Three Immunosuppressant Treatment Regimens in Patients Receiving a Liver Transplant for End-Stage Liver Disease Caused by Chronic Hepatitis C Infection

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • Hoffmann-La Roche

Registry information

Official study title

The Influence MMF on 5UTR HCV Quasispecies Variation: A Potential Factor in the Natural History of Post-OLT x HCV Infection

Important dates

Study start
2002
Primary completion
2007
Study completion
2007
First posted
Sep 15, 2005
Registry last updated
May 23, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.